Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jefferies
Manufacturing
Novo's Wegovy supply woes could soon be resolved: analysts
As Novo Nordisk has suggested, the problems behind Wegovy’s current supply hitch could be resolved within about six months.
Fraiser Kansteiner
Jan 27, 2022 9:20am
GSK rebuffs $68B buyout bid, but Unilever is undeterred
Jan 18, 2022 7:55am
Only $300K for Biogen's Aduhelm in Q3, far below consensus
Oct 20, 2021 10:23am
GSK's Shingrix rebound has yet to materialize, analysts say
Sep 16, 2021 9:32am
Apellis' Empaveli could reap $4B in race against Alexion drugs
Aug 19, 2021 11:50am
FDA set to approve COVID boosters for immunocompromised
Aug 12, 2021 9:54am
